Drug reference
durlobactam
Diazabicyclooctane β-lactamase inhibitor · Antibacterial; β-Lactamase Inhibitor
Diazabicyclooctane β-lactamase inhibitorAntibacterial; β-Lactamase Inhibitor
CDSCO approved
EXCRETION
—
not curated
INTERACTIONS
—
none in our sources
PREGNANCY
—
not curated
Mechanism
Novel non-β-lactam β-lactamase inhibitor, combined with sulbactam, for treatment of multidrug-resistant Acinetobacter infections.
Side effects
Serious
- Abnormal liver function tests
- Diarrhea
- Anemia
- Hypokalemia
Related guidelines
Ask House about durlobactam
Continue into a citation-backed clinical answer with the drug context already attached.
Textbook-sourced·Sources: Harrison 22e·Updated: 2026-05-10